Markets are Closed
NVS
Novartis AG
Open
—
Previous Open
High
87.65
Previous High
Low
87.13
Previous Low
Close
87.34
Previous Close
Volume
1,256,221
Previous Volume
Company Profile
Description
Novartis AG is a part of the healthcare industry. Its main activity is to research and develop healthcare products and pharmaceuticals such as oncology medicines, generic and biosimilar medicines and eye care devices.
Exchange
New York Stock Exchange
List Date
May 11, 2000
CEO
Joseph Jimenez
Employees
125,000
Related Stocks
Financials
Revenue
48.67B
Earnings
14.37B
58B
45B
33B
20B
7B
2015
2016
2017
2018
Splits
| May 11, 2000 | 0.50% |
Dividends
| March 15, 2021 | $2.20 |
| March 12, 2020 | $1.98 |
| March 12, 2020 | $2.01 |
| January 01, 1900 | $11.59 |
| March 13, 2019 | $1.84 |
| April 25, 2018 | $1.91 |
| April 20, 2017 | $2.30 |
| April 15, 2016 | $2.30 |
| April 20, 2015 | $2.26 |
| April 10, 2014 | $1.79 |
| April 05, 2013 | $2.06 |
Related News
ROSEN, A LEADING LAW FIRM, Continues to Investigate Securities Claims Against Novartis AG – NVS
Mar 09, 2020 @ 14:38
NEW YORK, March 09, 2020 -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Novartis AG....
finance yahoo
Teva's Two Pivotal Studies on Ajovy in Japan Meet Goal
Feb 04, 2020 @ 16:50
Teva (TEVA) posts positive results from two phase II/III studies on Ajovy for treating patients with chronic and episodic migraine in Japan....
finance yahoo
Is a Disappointment in Store for Glaxo's (GSK) Q4 Earnings?
Feb 03, 2020 @ 15:09
Glaxo's (GSK) Vaccines and Respiratory segments are likely to have driven sales in the fourth quarter....
finance yahoo
Pharma Stock Roundup: LLY, PFE Q4 Results, JNJ's Coronavirus Vaccine Initiative
Jan 31, 2020 @ 15:32
Lilly (LLY), Pfizer (PFE) and Novartis (NVS) announce Q4 results....
finance yahoo
Is Novartis AG (NVS) A Suitable Pick for Value Investors?
Jan 20, 2020 @ 14:45
Is Novartis AG (NVS) a great pick from the value investor's perspective right now? Read on to know more....
finance yahoo
Novartis (NVS) Gains But Lags Market: What You Should Know
Dec 12, 2019 @ 22:50
Novartis (NVS) closed the most recent trading day at $93.06, moving +0.02% from the previous trading session....
finance yahoo
Novartis (NVS) Gains But Lags Market: What You Should Know
Dec 05, 2019 @ 22:50
Novartis (NVS) closed at $91.64 in the latest trading session, marking a +0.09% move from the prior day....
finance yahooHas Novartis (NVS) Outpaced Other Medical Stocks This Year?
Aug 09, 2019 @ 13:30
Is (NVS) Outperforming Other Medical Stocks This Year?...
finance yahoo
Why Earnings Season Could Be Great for Novartis (NVS)
Jul 17, 2019 @ 14:48
Novartis (NVS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....
finance yahoo
From generic drugs to gummies: Boulder CBD company buys Novartis pharmaceutical plant in Broomfield for $18.8M
Jun 20, 2019 @ 20:23
A large pharmaceutical plant in Broomfield that for years produced generic drugs has been bought by a Boulder CBD company that’s looking to expand its ingredient-selling business to manufacturing mainstream products, like gummies, tablets and topicals. Mile High Labs purchased Novartis AG’s (NYSE: NVS) Sandoz plant in Broomfield, 2555 W. Midway Blvd., on Wednesday, June 19, for $18.8 million, company officials confirmed to Denver Business Journal....
finance yahooAll data provided on Polygon is provided for informational purposes only, and is not intended for trading or investing purposes.
Copyright © 2021, Polygon.io, Inc. All Rights Reserved.
TradingView Lightweight Chart: Copyright (с) 2020 TradingView, Inc. https://www.tradingview.com/